Finance·Jul 21, 2026
Samsung Biologics Bids $1.8 Billion for PolyPeptide in Korea's Largest Biopharma Acquisition
The all-cash deal marks Samsung's push into peptide manufacturing and extends its contract production footprint across new therapeutic modalities
By Jun-ho Seo · 3 min ·
